Immunohistochemical study of CD74 biomarker in normal and malignant breast tissues.

Q3 Medicine
Hayder Neamah Hassan, Rouaida Kadhim A Al-Hussein, Asmehan Adnan Al-Naqeeb
{"title":"Immunohistochemical study of CD74 biomarker in normal and malignant breast tissues.","authors":"Hayder Neamah Hassan, Rouaida Kadhim A Al-Hussein, Asmehan Adnan Al-Naqeeb","doi":"10.36740/Merkur202402113","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Aim: To detect the role of CD74 expression in breast carcinoma as a predictive marker for identifying the biological behavior of malignancy in Iraqi women..</p><p><strong>Patients and methods: </strong>Materials and Methods: The study used technique of immunohistochemistry for detection CD74 protein role in breast cancer, and its expression in breast cancer tissue samples. Samples were collected in Al-Najaf city in Iraq, from Al-Forat Al-Awsat Oncology Center. The study was achieved at the Laboratories of the Faculty of Science in the University of Kufa. Fifty samples of breast cancer tissue, and twenty controls benign tissue were included in the study. The study has investigated relationship between expression of biomarker with grade, age of patient and tumor size.</p><p><strong>Results: </strong>Results: The study showed that the cytoplasmic expression of CD74 with more clear and intensive staining in the cytoplasm, and reported that CD74 positivity rate was 52%. A significant association between CD74 expression and grade and size of tumor, so CD74 can be considered as a biomarker for prediction of breast cancer in women. No association was found between CD74 expression and each of patients' age and node metastasis.</p><p><strong>Conclusion: </strong>Conclusions: The study represents an important step in our region because there are a few studies about this topic; more efforts are required to approve the function of this biomarker.</p>","PeriodicalId":39518,"journal":{"name":"Polski Merkuriusz Lekarski","volume":"52 2","pages":"233-239"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Polski Merkuriusz Lekarski","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36740/Merkur202402113","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Aim: To detect the role of CD74 expression in breast carcinoma as a predictive marker for identifying the biological behavior of malignancy in Iraqi women..

Patients and methods: Materials and Methods: The study used technique of immunohistochemistry for detection CD74 protein role in breast cancer, and its expression in breast cancer tissue samples. Samples were collected in Al-Najaf city in Iraq, from Al-Forat Al-Awsat Oncology Center. The study was achieved at the Laboratories of the Faculty of Science in the University of Kufa. Fifty samples of breast cancer tissue, and twenty controls benign tissue were included in the study. The study has investigated relationship between expression of biomarker with grade, age of patient and tumor size.

Results: Results: The study showed that the cytoplasmic expression of CD74 with more clear and intensive staining in the cytoplasm, and reported that CD74 positivity rate was 52%. A significant association between CD74 expression and grade and size of tumor, so CD74 can be considered as a biomarker for prediction of breast cancer in women. No association was found between CD74 expression and each of patients' age and node metastasis.

Conclusion: Conclusions: The study represents an important step in our region because there are a few studies about this topic; more efforts are required to approve the function of this biomarker.

正常和恶性乳腺组织中 CD74 生物标记物的免疫组化研究
研究目的目的:检测CD74表达在乳腺癌中的作用,作为确定伊拉克妇女恶性肿瘤生物学行为的预测标志物:材料与方法本研究使用免疫组化技术检测 CD74 蛋白在乳腺癌中的作用及其在乳腺癌组织样本中的表达。样本采集于伊拉克纳杰夫市的 Al-Forat Al-Awsat 肿瘤中心。研究在库法大学理学院实验室完成。研究中包括 50 份乳腺癌组织样本和 20 份良性组织对照样本。研究调查了生物标志物的表达与等级、患者年龄和肿瘤大小之间的关系:结果:结果:研究显示,CD74在细胞质中的表达更清晰、染色更密集,CD74阳性率为52%。CD74 表达与肿瘤分级和大小有明显相关性,因此 CD74 可被视为预测女性乳腺癌的生物标记物。结论:CD74的表达与患者的年龄和结节转移之间没有关联:结论这项研究在我们地区迈出了重要的一步,因为有关这一主题的研究很少;需要做出更多努力来证实这一生物标志物的功能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Polski Merkuriusz Lekarski
Polski Merkuriusz Lekarski Medicine-Medicine (all)
CiteScore
1.90
自引率
0.00%
发文量
84
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信